mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.4 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.4 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |